As part of the collaboration, the companies will use Prellis Biologics' externalised human immune system (EXIS) which is based on human lymph node organoids (LNO). The human antibody The post Prellis, Bristol Myers Squibb collaborate to discover antibodies appeared first on Pharmaceutical Business review.
Prellis is a California-based biotechnology firm that develops and supplies 3D printed lymph nodes drug discovery and development systems for the healthcare industry.